Global Orphan Drugs Market 2014-2018
Published on: Jan 2014 No. of Pages: 66
Contact Us: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Mail us: sales@reportsandintelligence.com Detailed report at: http://www.reportsandintelligence.com/globalorphan-drugs-2014-2018-market Website: http://www.reportsandintelligence.com/
TechNavio's analysts forecast the Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018. One of the key factors contributing to this market growth is the shorter development timelines. The Global Orphan Drugs market has also been witnessing the growing awareness of orphan drugs. However, the high cost of drug development could pose a challenge to the growth of this market. TechNavio's report, the Global Orphan Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Orphan Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space are Novartis AG, F. Hoffmann-La Roche Ltd., Celgene Corp., Pfizer Inc., and Sanofi S.A. Other vendors mentioned in the report are Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals Inc., Amgen Inc., Baxter International Inc., Biogen Idec Inc., Bristol-Myers-Squibb Co., GlaxoSmithKline plc, Eli Lilly & Co., Merck KGaA, Novo Nordisk A/S, Onyx Pharmaceuticals Inc., Shire plc, and Vertex Pharmaceuticals Inc.
Key questions answered in this report: What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Table of Content: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Global Biologics Orphan Drugs Market Market Size and Forecast 06.4 Global Non-Biologic Orphan Drugs Market Market Size and Forecast 06.5 Five Forces Analysis 07. Market Segmentation by Product 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 16.1 Competitive Scenario 16.1.1 Key News 16.1.2 Mergers and Acquisitions
16.2 Market Share Analysis 2012 16.3 Other Prominent Vendors 17. Key Vendor Analysis 17.1 Novartis AG 17.1.1 Business Overview 17.1.2 Business Segmentation 17.1.3 Key Information 17.1.4 SWOT Analysis 17.2 F. Hoffmann La Roche Ltd. 17.2.1 Business Overview 17.2.2 Business Segmentation 17.2.3 Key Information 17.2.4 SWOT Analysis 17.3 Celgene Corp. 17.3.1 Business Overview 17.3.2 Key Information 17.3.3 SWOT Analysis 17.4 Pfizer Inc. 17.4.1 Business Overview 17.4.2 Key Information 17.4.3 SWOT Analysis 17.5 Sanofi S.A. 17.5.1 Business Overview 17.5.2 Business Segmentation 17.5.3 Key Information 17.5.4 SWOT Analysis 18. Other Reports in this Series
Get full TOC at: http://www.reportsandintelligence.com/global-orphan-drugs2014-2018-market/table-of-contents
Contact Us: Cathy Viber 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Fax: +1 (855) 550-5975 Mailto: sales@reportsandintelligence.com Web: http://www.reportsandintelligence.com Face book: https://www.facebook.com/reportsnintelligence